Operating Lease, Right-of-Use Asset of Immix Biopharma, Inc. from 31 Mar 2024 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Immix Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2024 to 30 Sep 2025.
Immix Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,005,434, a 0.47% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Immix Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$1,005,434	-$4,771	-0.47%	30 Sep 2025	10-Q	07 Nov 2025	2025	Q3
Q2 2025	$947,103	-$83,559	-8.1%	30 Jun 2025	10-Q	08 Aug 2025	2025	Q2
Q1 2025	$968,444	-$82,634	-7.9%	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	$989,471			31 Dec 2024	10-Q	07 Nov 2025	2025	Q3
Q3 2024	$1,010,205			30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q2 2024	$1,030,662			30 Jun 2024	10-Q	12 Aug 2024	2024	Q2
Q1 2024	$1,051,078			31 Mar 2024	10-Q	09 May 2024	2024	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.